Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in patients with obesity

Body Fat Distribution and Risk of Incident and Regressed Nonalcoholic Fatty Liver Disease

(2016) Donghee Kim et al.   Clinical Gastroenterology and Hepatology

Adipokines in nonalcoholic fatty liver disease

(2016) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Association of recently described adipokines with liver histology in biopsy-proven non-alcoholic fatty liver disease: a systematic review

(2015) M. Bekaert et al.   Obesity Reviews

Adipocytokines and hepatic fibrosis

(2015) Neeraj K. Saxena et al.   TRENDS IN ENDOCRINOLOGY AND METABOLISM

Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity

(2015) M G M Wolfs et al.   Nutrition & Diabetes

Noncanonical Wnt Signaling Promotes Obesity-Induced Adipose Tissue Inflammation and Metabolic Dysfunction Independent of Adipose Tissue Expansion

(2014) José J. Fuster et al.   DIABETES

Chemokine-Like Receptor 1 Deficiency Does Not Affect the Development of Insulin Resistance and Nonalcoholic Fatty Liver Disease in Mice

(2014) Nanda Gruben et al.   PLoS One

Elevated hepatic chemerin mRNA expression in human non-alcoholic fatty liver disease

(2013) S Döcke et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY

Characterization of the Wnt Inhibitors Secreted Frizzled-Related Proteins (SFRPs) in Human Adipose Tissue

(2013) Anna Ehrlund et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Cardioprotective Properties of Omentin-1 in Type 2 Diabetes: Evidence from Clinical and In Vitro Studies

(2013) Sabrina Greulich et al.   PLoS One

Secreted Frizzled-Related Protein 4 Reduces Insulin Secretion and Is Overexpressed in Type 2 Diabetes

(2012) Taman Mahdi et al.   Cell Metabolism

Nonalcoholic steatohepatitis versus steatosis: Adipose tissue insulin resistance and dysfunctional response to fat ingestion predict liver injury and altered glucose and lipoprotein metabolism

(2012) Giovanni Musso et al.   HEPATOLOGY

Predictors for incidence and remission of NAFLD in the general population during a seven-year prospective follow-up

(2012) Shira Zelber-Sagi et al.   JOURNAL OF HEPATOLOGY

Differential patterns of serum concentration and adipose tissue expression of chemerin in obesity: Adipose depot specificity and gender dimorphism

(2012) Assim A. Alfadda et al.   MOLECULES AND CELLS

Chemerin as biomarker for insulin sensitivity in males without typical characteristics of metabolic syndrome

(2012) D. Margriet Ouwens et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Effects of weight loss and exercise on chemerin serum concentrations and adipose tissue expression in human obesity

(2011) Rima Chakaroun et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Adipokines as novel biomarkers and regulators of the metabolic syndrome

(2010) Yingfeng Deng et al.   Annals of the New York Academy of Sciences

Molecular mechanisms of signal transduction via adiponectin and adiponectin receptors

(2010) John T. Heiker et al.   BIOLOGICAL CHEMISTRY

Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years

(2010) V. W.-S. Wong et al.   GUT

Chemerin Correlates with Markers for Fatty Liver in Morbidly Obese Patients and Strongly Decreases after Weight Loss Induced by Bariatric Surgery

(2010) Henrike Sell et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Serum total adiponectin in nonalcoholic fatty liver disease: a systematic review and meta-analysis

(2010) Stergios A. Polyzos et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Serum levels of omentin, chemerin and adipsin in patients with biopsy-proven nonalcoholic fatty liver disease

(2010) Yusuf Yilmaz et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Histopathology of nonalcoholic fatty liver disease

(2010) Elizabeth M Brunt   WORLD JOURNAL OF GASTROENTEROLOGY

Liver-Specific β-Catenin Knockout Mice Exhibit Defective Bile Acid and Cholesterol Homeostasis and Increased Susceptibility to Diet-Induced Steatohepatitis

(2009) Jaideep Behari et al.   AMERICAN JOURNAL OF PATHOLOGY

Chemerin Is a Novel Adipocyte-Derived Factor Inducing Insulin Resistance in Primary Human Skeletal Muscle Cells

(2009) Henrike Sell et al.   DIABETES

CCR2 promotes hepatic fibrosis in mice

(2009) Ekihiro Seki et al.   HEPATOLOGY

Chemerin Is Associated with Metabolic Syndrome Phenotypes in a Mexican-American Population

(2009) Kiymet Bozaoglu et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Mouse ChemR23 Is Expressed in Dendritic Cell Subsets and Macrophages, and Mediates an Anti-Inflammatory Activity of Chemerin in a Lung Disease Model

(2009) S. Luangsay et al.   JOURNAL OF IMMUNOLOGY